Lorenzo Oscar, Ruiz-Ortega Marta, Esbrit Pedro, Rupérez Mönica, Ortega Arantxa, Santos Soledad, Blanco Julia, Ortega Luis, Egido Jesus
Laboratory of Vascular and Renal Research, and Laboratory of Bone and Mineral Metabolism, Fundación Jiménez Díaz, Universidad Autónoma, Madrid, Spain.
J Am Soc Nephrol. 2002 Jun;13(6):1595-607. doi: 10.1097/01.asn.0000015622.33198.bf.
Angiotensin II (AngII) participates in the pathogenesis of kidney damage. Parathyroid hormone (PTH)-related protein (PTHrP), a vasodilator and mitogenic agent, is upregulated during renal injury. The aim of this study was to investigate the potential relation between AngII and PTHrP system in the kidney. Different methods were used to find that both rat mesangial and mouse tubuloepithelial cells express PTHrP and the type 1 PTH/PTHrP receptor (PTH1R). In these cells, AngII increased PTHrP mRNA and protein production. In contrast, PTH1R mRNA was increased in mesangial cells and downregulated in tubular cells, but its protein levels were unmodified in both cells. AT(1) antagonist, but not AT(2), abolished AngII effects on PTHrP/PTH1R. The in vivo effect of AngII was further investigated by systemic infusion (a low dose of 50 ng/kg per min) into normal rats. In controls, PTHrP immunostaining was mainly detected in renal tubules. In AngII-infused rats, PTHrP staining increased in renal tubules and appeared in the glomerulus and the renal vessels. After AngII infusion, PTHR1 staining was markedly increased in all these renal structures at day 3 but remained elevated only in tubules at day 7. The AT(1) antagonist, but not the AT(2), significantly diminished AngII-induced PTHrP and PTHR1 overexpression in the renal tissue, associated with a decrease in tubular damage and fibrosis. The results indicate that AngII regulates renal PTHrP/PTH1R system via AT(1) receptors. These findings demonstrate that PTHrP upregulation occurs in association with the mechanisms of AngII-induced kidney injury.
血管紧张素II(AngII)参与肾脏损伤的发病机制。甲状旁腺激素(PTH)相关蛋白(PTHrP)是一种血管舒张剂和促有丝分裂剂,在肾损伤时上调。本研究的目的是探讨肾脏中AngII与PTHrP系统之间的潜在关系。采用不同方法发现大鼠系膜细胞和小鼠肾小管上皮细胞均表达PTHrP和1型PTH/PTHrP受体(PTH1R)。在这些细胞中,AngII增加了PTHrP mRNA和蛋白的产生。相反,PTH1R mRNA在系膜细胞中增加而在肾小管细胞中下调,但其蛋白水平在两种细胞中均未改变。AT(1)拮抗剂而非AT(2)拮抗剂可消除AngII对PTHrP/PTH1R的作用。通过向正常大鼠全身输注(低剂量50 ng/kg每分钟)进一步研究了AngII的体内作用。在对照组中,PTHrP免疫染色主要在肾小管中检测到。在输注AngII的大鼠中,PTHrP染色在肾小管中增加并出现在肾小球和肾血管中。输注AngII后,第3天所有这些肾脏结构中的PTHR1染色均显著增加,但在第7天仅肾小管中仍保持升高。AT(1)拮抗剂而非AT(2)拮抗剂可显著减少AngII诱导的肾组织中PTHrP和PTHR1的过表达,同时伴有肾小管损伤和纤维化的减少。结果表明AngII通过AT(1)受体调节肾脏PTHrP/PTH1R系统。这些发现表明PTHrP上调与AngII诱导的肾损伤机制相关。